En español

Evgeny Krupitsky, M.D., Ph.D., D.M.Sc.

Evgeny Krupitsky , M.D., Ph.D., D.M.Sc.
Pavlov Medical University and Bekhterev Research
Psychoneurological Institute
St. Petersburg, Russia

Evgeny Krupitsky served as principal investigator for a multi-center Phase 3 clinical trial demonstrating that the alcohol abuse medication Vivitrol is an effective treatment for opioid dependence. Dr. Krupitsky’s work has helped identify the first non-narcotic, non-addictive, long-acting opioid dependence medication, providing a proven opioid pharmacotherapy option for residents of countries that ban other treatment medications. Throughout his career, Dr. Krupitsky has demonstrated an exceptional ability to translate basic science concepts into evidence-based drug policies and treatments. Working with colleagues in Russia and the United States, Dr. Krupitsky conducted the initial clinical epidemiological research on the prevalence of AIDS and its relationship to injection drug use in St. Petersburg, and then translated those findings into improved addiction policies and clinical practices in the region.

This page was last updated August 2010

Get this Publication

    2015 NIDA International Forum

    June 12 – 15, 2015
    Phoenix, Arizona
    Register Online

    Important Dates

    NIDA International Program Fellowships

    Application Deadlines:
    Postdoctoral Fellowships:
    April 1


    February 12 - February 16, 2015
    San Jose, California, USA
    March 3 - March 7, 2015
    Hyatt Regency New Orleans